Improving access to HPV vaccines for young girls in Nigeria
Official title: Research Project 1
Funded at Washington University · NIH-10931747 · Data updated 2026-11-12
This study is all about helping young girls in Nigeria get the HPV vaccine, which can protect them from certain cancers, by finding out what’s stopping them from getting it and working together with young people to come up with better ways to make the vaccine more accessible and raise awareness in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $205,312 |
| NIH project number | 5U54CA284110-02 |
| Project ID | NIH-10931747 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are girls aged 9-15 years old living in Nigeria.
✕Less likely to help
Patients outside the age range of 9-15 years or those not residing in Nigeria may not benefit from this research.
What this research studies
This research aims to address the barriers preventing young girls in Nigeria from accessing HPV vaccination, which is crucial for preventing HPV-associated cancers. By employing a youth participatory action research framework, the project will actively involve young people in creating solutions to improve vaccine uptake. The approach includes decentralizing vaccine access and utilizing local resources to enhance awareness and support within communities. The project will also implement innovative tools and participatory methods to engage youth and increase their involvement in health initiatives.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of HPV-associated cancers among young girls in Nigeria.
How similar studies have gone: Previous research has shown success in similar community-based approaches to increase vaccination rates, indicating potential for positive outcomes in this project.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.